Board of Directors

team headshots grey background

Edward Harvey

Chairman of the Board

Dr Harvey has a rich history of collaboration with basic, clinical and engineering scientists. He is a tenured Professor of Surgery at McGill University.  He is the Director of the Injury Repair and Rehabilitation program (one of only eight programs that make up the entire institute) at the MUHC-RI with over 100 investigators in his group. He is, or has been, editor-in-chief of the Canadian Journal of Surgery; editorial board member of the Journal of Orthopaedic Trauma and OTA International; chairman of the Research Committee and of the Annual Basic Science Course of the OTA; chair of the Trauma Section at the ORS; and president of the Canadian Orthopaedic Association amongst other national and international positions.

team headshots grey background

Charles Allan

Director

Charles has a passion for solving problems with MEMS technology. Prior to NXTSENS Microsystems Inc., he completed an M. Eng. at McGill University where he led an engineering team developing high precision MEMS absolute pressure sensors. In his B.Eng., Charles led a team that developed a miniature glaucoma pump. Currently he is leading the commercialization efforts of MY01, leveraging his passions for both business and engineering to ensure optimal user experience and adoption.

McLeod

Andrew McLeod

Director

Andrew McLeod is a senior executive who has built his more than 25 year career engrossed in the orthopaedic medical device arena. Andrew has strategically grown his career at DePuy Orthopaedics with a series of increasingly responsible positions, beginning as a marketing intern and sales associate and worked his way up to becoming Area Vice President of Sales in the Eastern US. This background prepared Andrew as the President and Chief Operations Officer for Medacta USA. Andrew became the Chief Commercial Officer for Bodycad.  He played an integral role in the commercialization of the first personalized device for Bodycad, the Bodycad Unicompartmental Knee. He lead the strategy for investment, strategic partnering, on-boarding of surgeon talent, sales force recruitment, pipeline/project management, European business development, and assisted with regulatory decisions/tasks. He then served as President of Corin USA. Andrew is currently the Vice President for US Commercial Spine Sales at DePuy Synthes. Andrew holds a Bachelor of Science in Biology from Purdue University and an MBA from Michigan State.

Maria Shepherd

Maria Shepherd

Independent Director

Maria launched Medi-Vantage in 2007 to help medtech clients grow profitably by applying her strategic expertise in the marketing, commercialization, and product development of medical devices. Since then, Medi-Vantage has worked to support (or decline) acquisitions, determine pricing strategy, commercialize disruptive medical device technologies, or assist product development teams in the design or re-engineering of medical devices. Maria developed her experience as an executive in large and start-up organizations. In her last industry role, Maria was vice president of marketing for Oridion, a start-up company acquired by Medtronic. Maria also served as director of marketing for Philips, serving the critical care patient monitoring division, and at Boston Scientific in senior management roles. Maria has direct industry experience as a subject matter expert in 12 medical specialties. Maria also serves on the board of MedExecWomen, an organization empowering female medtech executives to accelerate the positive impact of medical devices, diagnostics, drug delivery, and digital healthcare, with responsibility for its P&L. She holds an MBA from Babson College, magna cum laude, and BA in biology from the University of Pennsylvania.

Pierre Beaudoin

Pierre Beaudoin

Board Member

Pierre Beaudoin joined the Marine Products division of Bombardier in 1985. He occupied multiple positions such as Vice President of Product Development, Executive Vice President of the Sea-Doo/Ski-Doo division, and then President and Chief Operating Officer of Bombardier Recreational Products.
In February 2001, he was appointed President of Bombardier Aerospace, Business Aircraft and he became President and Chief Operating Officer of Bombardier Aerospace in October of the same year. In 2004, he was appointed Executive Vice President of Bombardier and became a member of the Board of Directors of Bombardier.  Following that, he was appointed roles such as President and Chief Executive Officer, Executive Chairman of the Board of Directors, and Chair of the Board of Directors. He is also a member of the Board of Directors of Power Corporation of Canada and of BRP Inc.

Louis-Etienne Fortier

Louis-Etienne Fortier

Board Member

Louis-Etienne Fortier joined Investissement Québec in January 2022 and is Senior Director, Investment, Life Sciences. He is responsible for the life sciences direct investment team, both for biotechnology and medical technology venture capital investment and for growth capital. CPA by training, Louis-Etienne combines nearly 20 years of experience in finance, including more than 10 years in investment roles, both in private equity and in venture capital, in different sectors of the economy. Before becoming an investor, Louis-Etienne notably held positions in commercial financing at the BDC, in financial advice at Deloitte.

Drew Trivisonno

Board Member

Drew is a proven investment professional with 20 years of experience in mergers & acquisitions, debt & equity financing, for both public & private companies. He has had a 10-year focus on capital raising and principal investing for the medical device industry. Drew completed debt and equity financings in the industry with capital providers such as Fortress Drawbridge Fund, Atherium Capital Management, PDL BioPharma, as well as, Xeraya Capital and Trevi Health Ventures. Drew has also brought in successful sales to companies Zimmer/Biomet and Stryker Corporation and has aided in successful a acquisition for Stryker Corporation.